2022
DOI: 10.1016/s2589-7500(22)00019-x
|View full text |Cite
|
Sign up to set email alerts
|

The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 41 publications
(19 citation statements)
references
References 51 publications
(318 reference statements)
1
18
0
Order By: Relevance
“…A systematic review of wearable sensors in detecting COVID-19 reported these investigations as promising but also highlighted the need for investigations in broader populations. 36 Based on this interim analysis, a 20 000-person randomised controlled trial is underway to test the real-time efficacy of the RNN algorithm which can act on real-time machine-learning-driven alerts about the likelihood of a COVID-19 infection before symptoms are reported. 13 The initial results from this larger trial are expected in December 2022, with a wider validation and more practical implications of the first presented data approach.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A systematic review of wearable sensors in detecting COVID-19 reported these investigations as promising but also highlighted the need for investigations in broader populations. 36 Based on this interim analysis, a 20 000-person randomised controlled trial is underway to test the real-time efficacy of the RNN algorithm which can act on real-time machine-learning-driven alerts about the likelihood of a COVID-19 infection before symptoms are reported. 13 The initial results from this larger trial are expected in December 2022, with a wider validation and more practical implications of the first presented data approach.…”
Section: Discussionmentioning
confidence: 99%
“…However, RT-PCR testing remains the most effective method to confirm COVID-19 infections. A systematic review of wearable sensors in detecting COVID-19 reported these investigations as promising but also highlighted the need for investigations in broader populations 36. Based on this interim analysis, a 20 000-person randomised controlled trial is underway to test the real-time efficacy of the RNN algorithm which can act on real-time machine-learning-driven alerts about the likelihood of a COVID-19 infection before symptoms are reported 13.…”
Section: Discussionmentioning
confidence: 99%
“…It was able to detect COVID-19 in the pre-symptomatic period as well as the symptomatic phase of the patients, with a precision score of 0.91 (CI: 0.854–0.967) [ 10 ]. Cho et al proposed a one-class SVM method that can detect COVID-19 23.5–40% earlier compared to the method of Mishra et al [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 ,…”
Section: Wearables As Digital Diagnosticsmentioning
confidence: 99%
“…The remotely accessed, real-time-monitored, continuous data recording in a personalized manner has made wearables an effective tool for the diagnosis of physiological conditions. It has been found that the physiological parameters obtained from these biosensors can be used in the detection of Lyme disease [ 1 ], respiratory infections, cardiovascular disorders [ 13 , 14 ], neurological disorders [ 15 ], coronavirus diseases [ 16 , 17 , 18 ], Parkinson’s disease [ 19 ], diabetes, liver diseases, and others. Not only can they detect physiological diseases, but wearables can also be employed to diagnose psychological states.…”
Section: Introductionmentioning
confidence: 99%
“…With the continued transmission of this virus around the world, there has been increasing demand for more convenient, sensitive, accurate, and inexpensive tests [ 1 , 2 ]. Currently, the SARS-CoV-2 analysis mainly depends on recognizing the following targets: nucleic acids [ [3] , [4] , [5] ], non-nucleic acids such as antigens [ [6] , [7] , [8] , [9] ], antibodies [ [10] , [11] , [12] ], associated biomarkers [ 13 , 14 ], symptom-related parameters [ 15 ], or multiplex factors [ 16 , 17 ]. Among these strategies, the real-time quantitative polymerase chain reaction (PCR) (RT-PCR) relying on nucleic acid amplification and detection is the most widely used and accurate [ 18 ].…”
Section: Introductionmentioning
confidence: 99%